MacKenzie Fiona M, Gould Ian M, Bruce Julie, Mollison Jill, Monnet Dominique L, Krcmery Vladimir, Cookson Barry, van der Meer Jos W M
Medical Microbiology, Aberdeen Royal Infirmary, Foresterhill, Aberdeen, UK.
J Hosp Infect. 2007 Jun;65 Suppl 2:73-81. doi: 10.1016/S0195-6701(07)60019-X.
This observational, cross-sectional study describes the role played by clinical microbiology and pharmacy departments in the stewardship of antibiotic prescribing in European hospitals. A total of 170 acute care hospitals from 32 European countries returned a questionnaire on antibiotic policies and practices implemented in 2001. Data on antibiotic use, expressed as Defined Daily Doses per 100 occupied bed-days (DDD/100 BD) were provided by 139 hospitals from 30 countries. A total of 124 hospitals provided both datasets. 121 (71%) of Clinical Microbiology departments and 66 (41%) of Pharmacy departments provided out of hours clinical advice. 70 (41%) of microbiology/infectious disease specialists and 28 (16%) of pharmacists visited wards on a daily basis. The majority of laboratories provided monitoring of blood cultures more than once per day and summary data of antibiotic susceptibility testing (AST) for empiric prescribing (86% and 73% respectively). Most of the key laboratory and pharmacy-led initiatives examined did not vary significantly by geographical location. Hospitals from the North and West of Europe were more likely to examine blood cultures more than once daily compared with other regions (p < 0.01). Hospitals in the North were least likely routinely to report susceptibility results for restricted antibiotics compared to those in the South-East and Central/Eastern Europe (p < 0.01). Hospital wards in the North were more likely to hold antibiotic stocks (100%) compared with hospitals in the South-East which were least likely (39%) (p < 0.001). Conversely, hospital pharmacies in the North were least likely to dispense antibiotics on an individual patient basis (16%) compared with hospital pharmacies from Southern Europe (60%) (p = 0.01). Hospitals that routinely reported susceptibility results for restricted antibiotics had significantly lower median total antibiotic use in 2001 (p < 0.01). Hospitals that provided prescribing advice outside normal working hours had significantly higher antibiotic use compared with institutions that did not provide this service (p = 0.01). A wide range of antibiotic stewardship measures was practised in the participating hospitals in 2001, although there remains great scope for expansion of those overseen by pharmacy departments. Most hospitals had active antibiotic stewardship programmes led by specialists in infection, although there is no evidence that these were associated with reduced antibiotic consumption. There was also no evidence that pharmacy services reduced the amount of antibiotics prescribed.
这项观察性横断面研究描述了临床微生物学和药学部门在欧洲医院抗生素处方管理中所发挥的作用。来自32个欧洲国家的170家急症医院返回了一份关于2001年实施的抗生素政策和做法的调查问卷。来自30个国家的139家医院提供了抗生素使用数据,以每100个占用床日的限定日剂量(DDD/100 BD)表示。共有124家医院提供了这两个数据集。121个(71%)临床微生物学部门和66个(41%)药学部门提供非工作时间的临床建议。70名(41%)微生物学/传染病专家和28名(16%)药剂师每天查房。大多数实验室每天对血培养进行不止一次监测,并提供用于经验性处方的抗生素敏感性试验(AST)汇总数据(分别为86%和73%)。所调查的大多数关键的由实验室和药学主导的举措在地理位置上没有显著差异。与其他地区相比,欧洲北部和西部的医院每天对血培养进行不止一次检查的可能性更大(p<0.01)。与东南欧和中东欧的医院相比,北部的医院常规报告限制使用抗生素敏感性结果的可能性最小(p<0.01)。北部的医院病房持有抗生素库存的可能性更大(100%),而东南部的医院可能性最小(39%)(p<0.001)。相反,与南欧的医院药房(60%)相比,北部的医院药房按个体患者配药的可能性最小(16%)(p = 0.01)。常规报告限制使用抗生素敏感性结果的医院在2001年的总抗生素使用中位数显著较低(p<0.01)。与不提供此项服务的机构相比,在正常工作时间之外提供处方建议的医院抗生素使用量显著更高(p = 0.01)。2001年参与研究的医院实施了广泛的抗生素管理措施,尽管由药学部门监督的措施仍有很大的扩展空间。大多数医院有由感染专家主导的积极的抗生素管理计划,尽管没有证据表明这些计划与抗生素消耗量的减少有关。也没有证据表明药学服务减少了抗生素的处方量。